|
CL2025003861A1
(es)
|
|
Formulaciones farmacéuticas de un agonista del receptor de amilina y un agonista del receptor de glp-1 que comprenden una ciclodextrina.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BR102022023461A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BY13167U
(https=)
|
|
|
|
BY13162U
(https=)
|
|
|
|
CN307045306S
(https=)
|
|
|
|
CN307044337S
(https=)
|
|
|
|
CN307044227S
(https=)
|
|
|
|
CN307045362S
(https=)
|
|
|
|
CN307045489S
(https=)
|
|
|
|
BY23963C1
(https=)
|
|
|
|
BY13176U
(https=)
|
|
|
|
CN307045528S
(https=)
|
|
|
|
BY13175U
(https=)
|
|
|
|
BY13174U
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|
|
BY13170U
(https=)
|
|
|
|
BY13169U
(https=)
|
|
|
|
BY13168U
(https=)
|
|
|
|
BY13157U
(https=)
|
|
|